Post-Exposure Prophylaxis
"Post-Exposure Prophylaxis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The prevention of infection or disease following exposure to a pathogen.
| Descriptor ID |
D056990
|
| MeSH Number(s) |
N02.421.726.755
|
| Concept/Terms |
Post-Exposure Prophylaxis- Post-Exposure Prophylaxis
- Post Exposure Prophylaxis
- Prophylaxis, Post-Exposure
- Post-Exposure Prevention
- Post Exposure Prevention
- Prevention, Post-Exposure
|
Below are MeSH descriptors whose meaning is more general than "Post-Exposure Prophylaxis".
Below are MeSH descriptors whose meaning is more specific than "Post-Exposure Prophylaxis".
This graph shows the total number of publications written about "Post-Exposure Prophylaxis" by people in this website by year, and whether "Post-Exposure Prophylaxis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2019 | 1 | 1 | 2 |
| 2021 | 0 | 2 | 2 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Post-Exposure Prophylaxis" by people in Profiles.
-
Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial. Clin Infect Dis. 2023 02 08; 76(3):e477-e486.
-
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains. Nature. 2021 08; 596(7870):103-108.
-
Immunogenicity after pre- and post-exposure rabies vaccination: A systematic review and dose-response meta-analysis. Vaccine. 2021 02 12; 39(7):1044-1050.
-
Varicella zoster immune globulin (human) (VARIZIG) in immunocompromised patients: a subgroup analysis for safety and outcomes from a large, expanded-access program. BMC Infect Dis. 2021 Jan 11; 21(1):46.
-
In vivo expressed biologics for infectious disease prophylaxis: rapid delivery of DNA-based antiviral antibodies. Emerg Microbes Infect. 2020 Dec; 9(1):1523-1533.
-
Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019. MMWR Recomm Rep. 2019 12 13; 68(4):1-14.
-
Window Period Prophylaxis for Children Exposed to Tuberculosis, Houston, Texas, USA, 2007-2017. Emerg Infect Dis. 2019 03; 25(3):523-528.
-
Prophylactic Antiepileptic Drug Use and Outcome in the Ethnic/Racial Variations of Intracerebral Hemorrhage Study. Stroke. 2015 Dec; 46(12):3532-5.
-
Immunogenicity and safety of four different dosing regimens of anthrax vaccine adsorbed for post-exposure prophylaxis for anthrax in adults. Vaccine. 2014 Oct 29; 32(47):6284-93.
-
A comparison of 2 strategies to prevent infection following pertussis exposure in vaccinated healthcare personnel. Clin Infect Dis. 2012 Apr; 54(7):938-45.